U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H14N2
Molecular Weight 210.2744
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NAPHAZOLINE

SMILES

C(C1=NCCN1)C2=CC=CC3=CC=CC=C23

InChI

InChIKey=CNIIGCLFLJGOGP-UHFFFAOYSA-N
InChI=1S/C14H14N2/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14/h1-7H,8-10H2,(H,15,16)

HIDE SMILES / InChI
Molecular Formula C14H14N2
Molecular Weight 210.2744
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:11:52 UTC 2023
Edited
by admin
on Fri Dec 15 15:11:52 UTC 2023
Record UNII
H231GF11BV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NAPHAZOLINE
INN   MART.   MI   VANDF   WHO-DD  
INN  
Official Name English
1H-IMIDAZOLE, 4,5-DIHYDRO-2-(1-NAPHTHALENYLMETHYL)-
Systematic Name English
NAPHAZOLINE [MART.]
Common Name English
2-(1-NAPHTHYLMETHYL)-2-IMIDAZOLINE
Systematic Name English
naphazoline [INN]
Common Name English
Naphazoline [WHO-DD]
Common Name English
NAPHAZOLINE [MI]
Common Name English
NAFAZOLIN
Brand Name English
NAPHAZOLINE [VANDF]
Common Name English
Classification Tree Code System Code
WHO-ATC S01GA51
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
WHO-ATC R01AB02
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
WHO-ATC R01AA08
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
WHO-VATC QS01GA51
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
WHO-VATC QR01AB02
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
WHO-ATC S01GA01
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
WHO-VATC QS01GA01
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
WHO-VATC QR01AA08
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
NCI_THESAURUS C29709
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
Code System Code Type Description
EVMPD
SUB09154MIG
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
FDA UNII
H231GF11BV
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
ChEMBL
CHEMBL761
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
IUPHAR
5509
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
RXCUI
7247
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY RxNorm
DRUG BANK
DB06711
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
CAS
835-31-4
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
WIKIPEDIA
NAPHAZOLINE
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
MERCK INDEX
m7723
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY Merck Index
PUBCHEM
4436
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
ECHA (EC/EINECS)
212-641-5
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
DAILYMED
H231GF11BV
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
EPA CompTox
DTXSID3048449
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
MESH
D009278
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
SMS_ID
100000084448
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
DRUG CENTRAL
3369
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
NCI_THESAURUS
C61856
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
INN
4153
Created by admin on Fri Dec 15 15:11:52 UTC 2023 , Edited by admin on Fri Dec 15 15:11:52 UTC 2023
PRIMARY
Related Record Type Details
ALPHA-1A ADRENERGIC RECEPTOR
TARGET -> AGONIST
Structure of NAPHAZOLINE NITRATE
SALT/SOLVATE -> PARENT
Structure of NAPHAZOLINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of NAPHAZOLINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966